Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021
Market Capitalization	407	355	336	1,655	1,692	2,051
Market Cap Growth	30.43%	5.88%	-79.72%	-2.19%	-17.53%	477.70%
Enterprise Value	-11	-167	-33	1,094	1,382	1,810
Last Close Price	9.98	7.92	7.63	36.13	37.96	58.90
PE Ratio	2.80	-	16.87	-	-	-
PS Ratio	61.44	-	69.54	174.08	200.54	236.73
PB Ratio	0.61	0.67	0.57	3.11	3.26	5.49
P/TBV Ratio	0.60	0.67	0.57	3.10	3.27	5.53
EV/Sales Ratio	-	-	-	115.15	163.83	208.87
EV/FCF Ratio	0.30	-	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.32	0.01	0.00	0.01
Net Debt / Equity Ratio	-0.66	-0.97	-0.69	-1.02	-0.90	-0.86
Net Debt / EBITDA Ratio	10.38	11.25	7.21	3.82	4.05	4.15
Net Debt / FCF Ratio	12.62	16.79	10.64	5.45	4.48	4.65
Asset Turnover	0.01	-	0.01	0.02	-	0.03
Quick Ratio	22.08	24.97	3.05	27.10	19.85	14.10
Current Ratio	22.25	25.19	3.06	27.34	20.08	14.27
Return on Equity (ROE)	24.48%	-12.39%	3.24%	-23.77%	-	-30.78%
Return on Assets (ROA)	-4.22%	-4.25%	-5.16%	-14.95%	-	-17.54%
Return on Capital Employed (ROCE)	-6.10%	-8.50%	-9.40%	-26.00%	-21.70%	-20.00%
Earnings Yield	35.69%	-19.54%	5.93%	-7.77%	-6.44%	-3.48%
FCF Yield	-8.63%	-8.64%	-11.32%	-6.04%	-6.14%	-3.37%
Buyback Yield / Dilution	-3.29%	-0.65%	-4.02%	-5.08%	-30.36%	-16.71%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.